[1]
2026. “Comparative study of the effectiveness of lipid nanoparticles in oral insulin delivery on blood sugar control in type 1 diabetic patients: a double-blind clinical trial”. Development Engineering Conferences Center Articles Database. 3, 12 (Jun. 2026).